[6-[[(3R,4S,5S,6R,7R,9R,10E,11S,12R,13S,14R)-10-[(2-chlorophenyl)methoxyimino]-6-[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-2-oxo-oxacyclotetradec-4-yl]oxy]-4-methoxy-2,4-dimethyloxan-3-yl] quinoxaline-2-carboxylate

C53H77ClN4O14 — CID 59903629

IUPAC[6-[[(3R,4S,5S,6R,7R,9R,10E,11S,12R,13S,14R)-10-[(2-chlorophenyl)methoxyimino]-6-[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-2-oxo-oxacyclotetradec-4-yl]oxy]-4-methoxy-2,4-dimethyloxan-3-yl] quinoxaline-2-carboxylate
SMILESCC[C@H]1OC(=O)[C@H](C)[C@@H](OC2CC(C)(OC)C(OC(=O)c3cnc4ccccc4n3)C(C)O2)[C@H](C)[C@@H](OC2OC(C)CC(N(C)C)C2O)[C@](C)(O)C[C@@H](C)/C(=N\OCc2ccccc2Cl)[C@H](C)[C@@H](O)[C@]1(C)O
InChIInChI=1S/C53H77ClN4O14/c1-14-40-53(10,64)45(60)30(4)42(57-66-27-34-19-15-16-20-35(34)54)28(2)24-51(8,63)46(72-50-43(59)39(58(11)12)23-29(3)67-50)31(5)44(32(6)48(61)69-40)70-41-25-52(9,65-13)47(33(7)68-41)71-49(62)38-26-55-36-21-17-18-22-37(36)56-38/h15-22,26,28-33,39-41,43-47,50,59-60,63-64H,14,23-25,27H2,1-13H3/b57-42+/t28-,29?,30+,31+,32-,33?,39?,40-,41?,43?,44+,45-,46-,47?,50?,51-,52?,53-/m1/s1
InChIKeyZKVAVGFJPQOPRW-QSBMBPRXSA-N
MW1029.67 g/mol
LogP6.25
Rot. Bonds12

About [6-[[(3R,4S,5S,6R,7R,9R,10E,11S,12R,13S,14R)-10-[(2-chlorophenyl)methoxyimino]-6-[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-2-oxo-oxacyclotetradec-4-yl]oxy]-4-methoxy-2,4-dimethyloxan-3-yl] quinoxaline-2-carboxylate

[6-[[(3R,4S,5S,6R,7R,9R,10E,11S,12R,13S,14R)-10-[(2-chlorophenyl)methoxyimino]-6-[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-2-oxo-oxacyclotetradec-4-yl]oxy]-4-methoxy-2,4-dimethyloxan-3-yl] quinoxaline-2-carboxylate (PubChem CID 59903629) has the molecular formula C53H77ClN4O14 and a molecular weight of 1029.67 g/mol. Its IUPAC name is [6-[[(3R,4S,5S,6R,7R,9R,10E,11S,12R,13S,14R)-10-[(2-chlorophenyl)methoxyimino]-6-[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-2-oxo-oxacyclotetradec-4-yl]oxy]-4-methoxy-2,4-dimethyloxan-3-yl] quinoxaline-2-carboxylate.

Molecular Properties

Compound Name[6-[[(3R,4S,5S,6R,7R,9R,10E,11S,12R,13S,14R)-10-[(2-chlorophenyl)methoxyimino]-6-[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-2-oxo-oxacyclotetradec-4-yl]oxy]-4-methoxy-2,4-dimethyloxan-3-yl] quinoxaline-2-carboxylate
PubChem CID59903629
Molecular FormulaC53H77ClN4O14
Molecular Weight1029.67 g/mol
Exact Mass1028.51
IUPAC Name[6-[[(3R,4S,5S,6R,7R,9R,10E,11S,12R,13S,14R)-10-[(2-chlorophenyl)methoxyimino]-6-[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-2-oxo-oxacyclotetradec-4-yl]oxy]-4-methoxy-2,4-dimethyloxan-3-yl] quinoxaline-2-carboxylate
SMILESCC[C@H]1OC(=O)[C@H](C)[C@@H](OC2CC(C)(OC)C(OC(=O)c3cnc4ccccc4n3)C(C)O2)[C@H](C)[C@@H](OC2OC(C)CC(N(C)C)C2O)[C@](C)(O)C[C@@H](C)/C(=N\OCc2ccccc2Cl)[C@H](C)[C@@H](O)[C@]1(C)O
InChIInChI=1S/C53H77ClN4O14/c1-14-40-53(10,64)45(60)30(4)42(57-66-27-34-19-15-16-20-35(34)54)28(2)24-51(8,63)46(72-50-43(59)39(58(11)12)23-29(3)67-50)31(5)44(32(6)48(61)69-40)70-41-25-52(9,65-13)47(33(7)68-41)71-49(62)38-26-55-36-21-17-18-22-37(36)56-38/h15-22,26,28-33,39-41,43-47,50,59-60,63-64H,14,23-25,27H2,1-13H3/b57-42+/t28-,29?,30+,31+,32-,33?,39?,40-,41?,43?,44+,45-,46-,47?,50?,51-,52?,53-/m1/s1
InChIKeyZKVAVGFJPQOPRW-QSBMBPRXSA-N
XLogP6.25
TPSA230.28 Ų
H-Bond Donors4
H-Bond Acceptors18
Rotatable Bonds12
Heavy Atoms72
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001029.67
LogP ≤ 56.25
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1018

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze [6-[[(3R,4S,5S,6R,7R,9R,10E,11S,12R,13S,14R)-10-[(2-chlorophenyl)methoxyimino]-6-[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-2-oxo-oxacyclotetradec-4-yl]oxy]-4-methoxy-2,4-dimethyloxan-3-yl] quinoxaline-2-carboxylate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [6-[[(3R,4S,5S,6R,7R,9R,10E,11S,12R,13S,14R)-10-[(2-chlorophenyl)methoxyimino]-6-[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-2-oxo-oxacyclotetradec-4-yl]oxy]-4-methoxy-2,4-dimethyloxan-3-yl] quinoxaline-2-carboxylate?
The IUPAC name of [6-[[(3R,4S,5S,6R,7R,9R,10E,11S,12R,13S,14R)-10-[(2-chlorophenyl)methoxyimino]-6-[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-2-oxo-oxacyclotetradec-4-yl]oxy]-4-methoxy-2,4-dimethyloxan-3-yl] quinoxaline-2-carboxylate (CID 59903629) is [6-[[(3R,4S,5S,6R,7R,9R,10E,11S,12R,13S,14R)-10-[(2-chlorophenyl)methoxyimino]-6-[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-2-oxo-oxacyclotetradec-4-yl]oxy]-4-methoxy-2,4-dimethyloxan-3-yl] quinoxaline-2-carboxylate.
What is the SMILES notation for [6-[[(3R,4S,5S,6R,7R,9R,10E,11S,12R,13S,14R)-10-[(2-chlorophenyl)methoxyimino]-6-[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-2-oxo-oxacyclotetradec-4-yl]oxy]-4-methoxy-2,4-dimethyloxan-3-yl] quinoxaline-2-carboxylate?
The canonical SMILES for [6-[[(3R,4S,5S,6R,7R,9R,10E,11S,12R,13S,14R)-10-[(2-chlorophenyl)methoxyimino]-6-[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-2-oxo-oxacyclotetradec-4-yl]oxy]-4-methoxy-2,4-dimethyloxan-3-yl] quinoxaline-2-carboxylate is CC[C@H]1OC(=O)[C@H](C)[C@@H](OC2CC(C)(OC)C(OC(=O)c3cnc4ccccc4n3)C(C)O2)[C@H](C)[C@@H](OC2OC(C)CC(N(C)C)C2O)[C@](C)(O)C[C@@H](C)/C(=N\OCc2ccccc2Cl)[C@H](C)[C@@H](O)[C@]1(C)O.
What is the InChIKey of [6-[[(3R,4S,5S,6R,7R,9R,10E,11S,12R,13S,14R)-10-[(2-chlorophenyl)methoxyimino]-6-[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-2-oxo-oxacyclotetradec-4-yl]oxy]-4-methoxy-2,4-dimethyloxan-3-yl] quinoxaline-2-carboxylate?
The InChIKey is ZKVAVGFJPQOPRW-QSBMBPRXSA-N. The full InChI is InChI=1S/C53H77ClN4O14/c1-14-40-53(10,64)45(60)30(4)42(57-66-27-34-19-15-16-20-35(34)54)28(2)24-51(8,63)46(72-50-43(59)39(58(11)12)23-29(3)67-50)31(5)44(32(6)48(61)69-40)70-41-25-52(9,65-13)47(33(7)68-41)71-49(62)38-26-55-36-21-17-18-22-37(36)56-38/h15-22,26,28-33,39-41,43-47,50,59-60,63-64H,14,23-25,27H2,1-13H3/b57-42+/t28-,29?,30+,31+,32-,33?,39?,40-,41?,43?,44+,45-,46-,47?,50?,51-,52?,53-/m1/s1.
What are the key properties of [6-[[(3R,4S,5S,6R,7R,9R,10E,11S,12R,13S,14R)-10-[(2-chlorophenyl)methoxyimino]-6-[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-2-oxo-oxacyclotetradec-4-yl]oxy]-4-methoxy-2,4-dimethyloxan-3-yl] quinoxaline-2-carboxylate?
[6-[[(3R,4S,5S,6R,7R,9R,10E,11S,12R,13S,14R)-10-[(2-chlorophenyl)methoxyimino]-6-[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-2-oxo-oxacyclotetradec-4-yl]oxy]-4-methoxy-2,4-dimethyloxan-3-yl] quinoxaline-2-carboxylate has a molecular weight of 1029.67 g/mol, XLogP of 6.25, 12 rotatable bonds, 4 hydrogen bond donors, and 18 hydrogen bond acceptors.
Where does this data come from?
All data for [6-[[(3R,4S,5S,6R,7R,9R,10E,11S,12R,13S,14R)-10-[(2-chlorophenyl)methoxyimino]-6-[4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-2-oxo-oxacyclotetradec-4-yl]oxy]-4-methoxy-2,4-dimethyloxan-3-yl] quinoxaline-2-carboxylate is sourced from PubChem (CID 59903629), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).